Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $13.9300 (2.77%) ($13.9300 - $13.9300) on Thu. Apr. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.06% (three month average) | RSI | 23 | Latest Price | $13.9300(2.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -12% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(68%) IWC(61%) IWO(61%) IBUY(60%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.53% in a week (0% probabilities). VIXM(-29%) UUP(-15%) VXX(-10%) TBT(-8%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.53% (StdDev 5.06%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.04(-172.07%) | Resistance Level | $16.91 | 5 Day Moving Average | $14.2(-1.9%) | 10 Day Moving Average | $14.84(-6.13%) | 20 Day Moving Average | $16.91(-17.62%) | To recent high | -34.7% | To recent low | 2.8% | Market Cap | $865m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |